You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission
|
|---|---|
| Published in |
Cancer Immunology, Immunotherapy, October 2011
|
| DOI | 10.1007/s00262-011-1081-8 |
| Pubmed ID | |
| Authors |
Christina S. Chu, Jean Boyer, Daniel S. Schullery, Phyllis A. Gimotty, Victoria Gamerman, James Bender, Bruce L. Levine, George Coukos, Stephen C. Rubin, Mark A. Morgan, Robert H. Vonderheide, Carl H. June |
| Abstract |
In spite of increased rates of complete response to initial chemotherapy, most patients with advanced ovarian cancer relapse and succumb to progressive disease. Immunotherapy may have potential for consolidation therapy. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 2 | 2% |
| United Kingdom | 1 | 1% |
| Austria | 1 | 1% |
| Unknown | 96 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 23 | 23% |
| Student > Ph. D. Student | 17 | 17% |
| Student > Master | 12 | 12% |
| Student > Bachelor | 10 | 10% |
| Other | 8 | 8% |
| Other | 17 | 17% |
| Unknown | 13 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 40 | 40% |
| Agricultural and Biological Sciences | 19 | 19% |
| Immunology and Microbiology | 7 | 7% |
| Biochemistry, Genetics and Molecular Biology | 5 | 5% |
| Nursing and Health Professions | 3 | 3% |
| Other | 10 | 10% |
| Unknown | 16 | 16% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 November 2020.
All research outputs
#4,142,796
of 22,655,397 outputs
Outputs from Cancer Immunology, Immunotherapy
#429
of 2,882 outputs
Outputs of similar age
#23,975
of 139,896 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#5
of 39 outputs
Altmetric has tracked 22,655,397 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,882 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 139,896 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.